Sign in
4

Changes in Ownership

HERON THERAPEUTICS, INC. /DE/ Filed Acc 0001209191-19-051413

Options or other derivatives

  • Director acquired 25,750 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

DAVIS STEPHEN · Director

Table II: Derivative

2 lines
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2019-10-01 Grant or award : show line 1 in the form Stock Option (Right to Buy) +25,000 $17.56 2029-10-01 25,000 25,000 D
2019-10-01 Grant or award : show line 2 in the form Stock Option (Right to Buy) +750 $17.56 2029-10-01 750 750 D
Loading xslF345X03/doc4.xml…